![]() | ![]() |
Formats:
|
||||
Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation. This article has been cited by other articles in PMC.Abstract A combination of mustine, vincristine (Oncovin), procarbazine, and prednisione (MOPP) and the same combination without prednisone (MOP) were compared in the treatment of stage IV Hodgkin's disease in a prospective randomized trial. The complete remission rates were 80% with MOPP and 44% with MOP; the difference was highly significant. Prednisone seems to be an important component of the MOPP combination in the management of stage IV Hodgkin's disease. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (579K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. Images in this article Click on the image to see a larger version. Selected References These references are in PubMed. This may not be the complete list of references from this article.
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||